ATC code N04
ATC code N04 Anti-parkinson drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup N04 is part of the anatomical group N Nervous system. Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN04. National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
| ATC code N: Nervous system |
|---|
|
| ATCvet only |
|
| Other ATC codes |
ATC code N04 Anti-parkinson drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup N04 is part of the anatomical group N Nervous system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN04.[5]
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
N04A Anticholinergic agents
[edit]N04AA Tertiary amines
[edit]- N04AA01 Trihexyphenidyl
- N04AA02 Biperiden
- N04AA03 Metixene
- N04AA04 Procyclidine
- N04AA05 Profenamine
- N04AA08 Dexetimide
- N04AA09 Phenglutarimide
- N04AA10 Mazaticol
- N04AA11 Bornaprine
- N04AA12 Tropatepine
N04AB Ethers chemically close to antihistamines
[edit]- N04AB01 Etanautine
- N04AB02 Orphenadrine (chloride)
- N04AC01 Benzatropine
- N04AC30 Etybenzatropine
N04B Dopaminergic agents
[edit]N04BA Dopa and dopa derivatives
[edit]- N04BA01 Levodopa
- N04BA02 Levodopa and decarboxylase inhibitor
- N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor
- N04BA04 Melevodopa
- N04BA05 Melevodopa and decarboxylase inhibitor
- N04BA06 Etilevodopa and decarboxylase inhibitor
- N04BA07 Foslevodopa and decarboxylase inhibitor
N04BB Adamantane derivatives
[edit]- N04BB01 Amantadine
N04BC Dopamine agonists
[edit]- N04BC01 Bromocriptine
- N04BC02 Pergolide
- N04BC03 Dihydroergocryptine mesylate
- N04BC04 Ropinirole
- N04BC05 Pramipexole
- N04BC06 Cabergoline
- N04BC07 Apomorphine
- N04BC08 Piribedil
- N04BC09 Rotigotine
- N04BD01 Selegiline
- N04BD02 Rasagiline
- N04BD03 Safinamide
N04BX Other dopaminergic agents
[edit]- N04BX01 Tolcapone
- N04BX02 Entacapone
- N04BX03 Budipine
- N04BX04 Opicapone
N04C Other antiparkinson drugs
[edit]N04CX Other antiparkinson drugs
[edit]- N04CX01 Istradefylline
References
[edit]- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code N04". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QN04". WHO Collaborating Centre for Drug Statistics Methodology.